METOPIRONE: payments to doctors
Payments that named METOPIRONE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Esteve Pharmaceuticals LLC?
Esteve Pharmaceuticals LLC reported the most payments naming METOPIRONE. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $102K
- Providers
- 37
- Transactions
- 50
- Average per transaction
- $2,046
The per-transaction average — $2,046 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 37 providers the average total is $2,765, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Esteve Pharmaceuticals LLC | $76,084 | 74.4% |
| HRA Pharma RARE Diseases | $26,214 | 25.6% |
Other products from Esteve Pharmaceuticals LLC
The company that reported the most payments naming METOPIRONE also reports against these.